Theranos
closedBlood testing and early disease detection services.
Launch date
–
Employees
Market cap
-
Enterprise valuation
€1 (Public information from Sep 2018)
Palo Alto California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A Valuation: $9.0b | Late VC | |
$349m | Growth Equity VC | ||
$582m | Secondary | ||
* |
| $100m | Debt |
* | N/A | N/A | Bankruptcy |
| Total Funding | €624m | ||
Related Content
Recent News about Theranos
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.